PMDA — authorised 23 June 2021
- Marketing authorisation holder: MSD K.K.
- Status: approved
🇯🇵 Recarbrio in Japan
PMDA authorised Recarbrio on 23 June 2021
Marketing authorisation
Recarbrio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Japan
Frequently asked questions
Is Recarbrio approved in Japan?
Yes. PMDA authorised it on 23 June 2021.
Who is the marketing authorisation holder for Recarbrio in Japan?
MSD K.K. holds the Japanese marketing authorisation.